CRISPR: Possibilities & Limitations for Connective Tissue Conditions

CRISPR, a revolutionary gene-editing tool, holds promise in potentially correcting the genetic mutations in certain conditions.
In this session, the potential of CRISPR technology in treating Marfan syndrome and related conditions is explored, while also delving into the limitations that accompany such groundbreaking advancements.
Speakers:
Benjamin Kleinstiver, PhD; Massachusetts General Hospital
Mark Lindsay, MD, PhD; Massachusetts General Hospital
Panelists:
Peter Byers, MD; University of Washington
Hal Dietz, MD; Johns Hopkins University School of Medicine
Dianna Milewicz, MD, PhD; UTHealth Houston

[@ruthbloom6480]

So amazing to be able to part of the discussion of the future of CRISPR technology. The presenters were spoke clearly to their online audience with respect and compassion. Thank you.

[@susannahXD]

Look at these four legends getting together to try to understand and potentially repair the human body

[@chantalgates9018]

Chantal VED Ontario, Canada

[@crumpfyllc5571]

My age is 20. Does this thing will cure my eye lenses, Aorta, Scoliosis, chest bone without too many operations? I am tired of life. My friends and cousins are healthy and enjoying their life.

[@yolandagarciagrajeda9261]

Pero pienso que es un tema muy interesante ya que mi hijo lo padece

[@yolandagarciagrajeda9261]

Lobpueden traducir al español porque no le entiendo